Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Drugs like PDEI may help hair disorders like AGA.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Vasodilators may worsen abdominal aortic aneurysm.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Antiandrogen therapy helps treat genetic hair loss.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Injection therapies show promise as effective treatments for hair loss.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Men and women react differently to opioids, with hormones potentially influencing these differences.